Clinical Trial Update: A Phase 3 Clinical Study of KHK4827 [Phase 3]

View source ↗

Summary

The document notes that Kyowa Kirin's Phase 3 study of KHK4827 for psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• KHK4827

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED